Please assess the completion status of the following clinical trial:

Trial Title: Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Caesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* full-term singleton pregnant women~* American society of anesthesiologist I or II,~* scheduled for elective cesarean delivery~Exclusion Criteria:~* Patients with uncontrolled cardiac morbidities (patients with tight valvular lesion, impaired contractility with ejection fraction \< 50%, heart block, and arrhythmias),~* hypertensive disorders of pregnancy,~* peripartum bleeding,~* coagulation disorders (patients with INR \>1.4 and or platelet count \< 80000 /dL)~* any contraindication to regional anesthesia,~* baseline systolic blood pressure (SBP) \< 100 mmHg will be excluded from the study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- epinephrine 0.03 mcg (Type: ACTIVE_COMPARATOR): None
- epinephrine 0.05 mcg (Type: ACTIVE_COMPARATOR): None
- epinephrine 0.07 mcg (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).